Literature DB >> 21139040

The bioflavonoid kaempferol is an Abcg2 substrate and inhibits Abcg2-mediated quercetin efflux.

Guohua An1, Jorge Gallegos, Marilyn E Morris.   

Abstract

The flavonoids quercetin and kaempferol are major constituents of Ginkgo biloba extract. The ATP-binding cassette efflux transporter, breast cancer resistance protein (Bcrp, Abcg2), is involved in the transport of quercetin and represents a possible mechanism for the low bioavailability of quercetin. Our objective was to investigate whether kaempferol inhibits Bcrp-mediated quercetin efflux and determine whether it is a substrate for BCRP. The intracellular uptake of kaempferol, with and without specific inhibitors, was determined in Bcrp-expressing cells. The transport of quercetin or kaempferol (10 μM) across Madin-Darby canine kidney (MDCK) cell monolayers was investigated in both the apical (A)-to-basolateral (B) and B-to-A directions. Samples were analyzed using liquid chromatography-tandem mass spectrometry. Compared with the quercetin alone group, the transport ratio decreased 11.6-fold (from 97.5 to 8.37) in the presence of kaempferol in MDCK/Bcrp1 cells, indicating that kaempferol is a Bcrp inhibitor. The intracellular concentration of kaempferol was significantly increased in the presence of N-(4-[2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]-phenyl)-9,10-dihydro-5-methoxy-9-oxo-4-acridine carboxamide (GF120918), a potent Bcrp inhibitor, suggesting that kaempferol may also be a Bcrp substrate. Moreover, in MDCK/Bcrp1 cells, the P(app, B-A) of kaempferol was much higher (17.7 ± 3.8 × 10(-6) cm/s) than the P(app, A-B) (0.279 ± 0.037 × 10(-6) cm/s), with a transport ratio of 63.4. In contrast, the transport ratio of kaempferol was only 0.68 in Bcrp1-negative MDCK/Mock cells. We report for the first time that kaempferol is a Bcrp substrate, and our results indicate that kaempferol inhibits Bcrp-mediated quercetin efflux. Intestinal efflux by Bcrp may represent one possible mechanism for the low bioavailability of kaempferol. The use of flavonoids in combination may increase their bioavailability through transport interactions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21139040     DOI: 10.1124/dmd.110.035212

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  24 in total

1.  In Vivo Exposure of Kaempferol Is Driven by Phase II Metabolic Enzymes and Efflux Transporters.

Authors:  Liang Zheng; Lijun Zhu; Min Zhao; Jian Shi; Yuhuan Li; Jia Yu; Huangyu Jiang; Jinjun Wu; Yunli Tong; Yuting Liu; Ming Hu; Linlin Lu; Zhongqiu Liu
Journal:  AAPS J       Date:  2016-07-08       Impact factor: 4.009

Review 2.  Potential Influence of Centrally Acting Herbal Drugs on Transporters at the Blood-Cerebrospinal Fluid Barrier and Blood-Brain Barrier.

Authors:  Lilian W Kibathi; SoHyun Bae; Scott R Penzak; Parag Kumar
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-12       Impact factor: 2.441

Review 3.  Therapeutic Potential and Utility of Elacridar with Respect to P-glycoprotein Inhibition: An Insight from the Published In Vitro, Preclinical and Clinical Studies.

Authors:  Ranjeet Prasad Dash; R Jayachandra Babu; Nuggehally R Srinivas
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-12       Impact factor: 2.441

4.  Mutual interactions between flavonoids and enzymatic and transporter elements responsible for flavonoid disposition via phase II metabolic pathways.

Authors:  Wen Jiang; Ming Hu
Journal:  RSC Adv       Date:  2012-09-21       Impact factor: 3.361

5.  Protective effect of kaempferol on LPS plus ATP-induced inflammatory response in cardiac fibroblasts.

Authors:  Xi-Lan Tang; Jian-Xun Liu; Wei Dong; Peng Li; Lei Li; Jin-Cai Hou; Yong-Qiu Zheng; Cheng-Ren Lin; Jun-Guo Ren
Journal:  Inflammation       Date:  2015-02       Impact factor: 4.092

Review 6.  The Role of Secondary Metabolites on Gynecologic Cancer Therapy: Some Pathways and Mechanisms.

Authors:  Mürşide Ayşe Demirel; İpek Süntar
Journal:  Turk J Pharm Sci       Date:  2017-11-20

7.  Human ABCG2: structure, function, and its role in multidrug resistance.

Authors:  Wei Mo; Jian-Ting Zhang
Journal:  Int J Biochem Mol Biol       Date:  2011-03-30

Review 8.  A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention.

Authors:  Allen Y Chen; Yi Charlie Chen
Journal:  Food Chem       Date:  2012-12-28       Impact factor: 7.514

Review 9.  Multidrug-resistant cancer cells and cancer stem cells hijack cellular systems to circumvent systemic therapies, can natural products reverse this?

Authors:  Qian Zhang; Yunjiang Feng; Derek Kennedy
Journal:  Cell Mol Life Sci       Date:  2016-09-12       Impact factor: 9.261

Review 10.  Plants vs. cancer: a review on natural phytochemicals in preventing and treating cancers and their druggability.

Authors:  Hu Wang; Tin Oo Khor; Limin Shu; Zheng-Yuan Su; Francisco Fuentes; Jong-Hun Lee; Ah-Ng Tony Kong
Journal:  Anticancer Agents Med Chem       Date:  2012-12       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.